Neha Agarwal co-leads PATH’s Diagnostics program, which focuses on developing and advancing a portfolio of high-impact, affordable, and easy-to-use diagnostic tools and technologies suitable for adoption in low- and middle-income countries. Her work focuses on addressing access challenges in low- and middle-income countries and spans a multitude of health areas, including primary health, infectious diseases, and now COVID-19.
Neha has held previous positions at the Clinton Health Access Initiative and Applied Strategies, applying decision science in supporting portfolio management for several global health donors. Prior to her work in global health, Neha started her career in the medical technology industry, focusing on innovative product development at companies such as Johnson & Johnson and Verinata Health (now Illumina), earning her several patents for lab-on-chip and drug delivery technologies.
Neha received her Master of Science in Biomedical Engineering from Columbia University and her Bachelor of Science in Bioengineering from University of California, Berkeley. She also serves on the Board of Advisors for the Bay Area Global Health Alliance.